Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments by Maria Lucia Iacovino, Simone Talucci, Laura Arenare, Andrea Caglio, Andrea Canciello, Flavio Salerno, Sergio Facchini, Adriano Gravina, Clorinda Schettino, Maria Carmela Piccirillo, Pier Paolo Olimpieri, Massimo Di Maio, Francesco Perrone

Get full text